Radiation Induces Up-Regulation of Somatostatin Receptors 1, 2, and 5 in Small Cell Lung Cancer In Vitro Also at Low Absorbed Doses-Reference-Cited by-同舟云学术

Radiation Induces Up-Regulation of Somatostatin Receptors 1, 2, and 5 in Small Cell Lung Cancer In Vitro Also at Low Absorbed Doses

Published:2011-12 Issue:6 Volume:26 Page:759-765
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Oddstig Jenny¹,Bernhardt Peter¹,Nilsson Ola²,Ahlman Håkan³,Forssell-Aronsson Eva¹

Affiliation:

1. Department of Radiation Physics, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.

2. Department of Pathology, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.

3. Department of Surgery, Lundberg Laboratory for Cancer Research, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2010.0921

Reference39 articles.

1. Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors

2. Preclinical and Clinical Studies of Peptide Receptor Radionuclide Therapy

3. [177Lu-DOTA0-Tyr3]-Octreotate Treatment in Patients with Disseminated Gastroenteropancreatic Neuroendocrine Tumors: The Value of Measuring Absorbed Dose to the Kidney

4. Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors

5. Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future Treatment Strategies for Cancer Patients Combining Targeted Alpha Therapy with Pillars of Cancer Treatment: External Beam Radiation Therapy, Checkpoint Inhibition Immunotherapy, Cytostatic Chemotherapy, and Brachytherapy;Pharmaceuticals;2024-08-05

2. Theranostics in Neurooncology: Heading Toward New Horizons;Journal of Nuclear Medicine;2023-12-07

3. Structural modifications toward improved lead-203/lead-212 peptide-based image-guided alpha-particle radiopharmaceutical therapies for neuroendocrine tumors;European Journal of Nuclear Medicine and Molecular Imaging;2023-11-13

4. Somatostatin Receptor Theranostics for Refractory Meningiomas;Current Oncology;2022-08-04

5. Hyperfractionated Treatment with 177Lu-Octreotate Increases Tumor Response in Human Small-Intestine Neuroendocrine GOT1 Tumor Model;Cancers;2022-01-04